|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | |||||||||||
| Available-for-sale marketable securities | |||||||||||
| Prepaid expenses and other current assets | |||||||||||
| Total current assets | |||||||||||
| Restricted cash | |||||||||||
| Property and equipment, net | |||||||||||
| Operating lease right-of-use assets | |||||||||||
| Finance lease right-of-use assets | |||||||||||
| Other non-current assets | |||||||||||
| Total assets | |||||||||||
| Liabilities, and stockholders' equity | |||||||||||
| Current liabilities | |||||||||||
| Accounts payable | |||||||||||
| Accrued compensation | |||||||||||
| Accrued license expense - related party | |||||||||||
| Other accrued expenses and current liabilities | |||||||||||
| Operating lease liabilities, short-term portion | |||||||||||
| Finance lease liabilities | |||||||||||
| Total current liabilities | |||||||||||
| Operating lease liabilities, net of short-term portion | |||||||||||
| Finance lease liabilities, net of short-term portion | |||||||||||
| Other non-current liabilities | |||||||||||
| Term loan | |||||||||||
| Total liabilities | |||||||||||
| Redeemable convertible preferred stock, no par value; no shares authorized, issued and outstanding as of December 31, 2024 $0.00001 par value 114,556,997 shares authorized as of December 31, 2023; 114,556,997 shares issued and outstanding as of December 31, 2023; liquidation preference of $181,273 as of December 31, 2023 | |||||||||||
| Stockholders' equity | |||||||||||
| Preferred stock, $0.00001 par value, 10,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025 | |||||||||||
| Common stock, $0.00001 par value, 490,000,000 shares authorized; 62,537,376 and 60,389,893 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive (loss) income | |||||||||||
| Accumulated deficit | |||||||||||
| Total stockholders' equity | |||||||||||
| Total liabilities and stockholders' equity |
Loading...